New dye could spare thousands of women from unnecessary lymph node removal
NCT ID NCT06868238
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study tests a new dye called Magtrace that stays in the lymph nodes for weeks. For women with non-invasive breast cancer (DCIS) having a mastectomy, this dye may allow doctors to safely delay lymph node removal until after the breast tissue is checked for hidden invasive cancer. The goal is to avoid unnecessary lymph node surgery in most patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Radiation may let breast cancer patients keep their nipple
- Which workout wins for breast cancer recovery? a trial puts cardio vs conditioning to the test
- Could a Post-Workout protein shake help breast cancer survivors rebuild muscle?
- Hidden heart risk: routine cancer scans could reveal cardiovascular danger in breast cancer survivors
- Exercise after breast cancer: which workout best boosts healing muscle signals?